|
Market Closed -
Nasdaq
23:00:00 21/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.6248 USD | +4.99% |
|
+6.62% | -46.14% |
| Market Cap | 53.9M 48.03M 44.47M 40.24M 75.82M 5.09B 76.72M 533M 209M 2.67B 202M 198M 8.52B | P/E 2026 * |
-1.36x | P/E 2027 * | -1.34x |
|---|---|---|---|---|---|
| Enterprise Value | 53.9M 48.03M 44.47M 40.24M 75.82M 5.09B 76.72M 533M 209M 2.67B 202M 198M 8.52B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
94.98% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| RNTX | Delayed | |
CBOE
| RNTX | Real-time | |
|
Tradegate
| 015A | Real-time |
Last Transcript: Rein Therapeutics Inc.
| 1 day | +4.99% | ||
| 1 week | +6.62% | ||
| Current month | -22.29% | ||
| 1 month | -21.36% | ||
| 3 months | -30.17% | ||
| 6 months | -66.59% | ||
| Current year | -46.14% |
| 1 week | 0.54 |  | 0.65 |
| 1 month | 0.54 | | 0.9 |
| Current year | 0.54 | | 2.1 |
| 1 year | 0.54 | | 2.18 |
| 3 years | 0.54 | | 7.42 |
| 5 years | 0.54 | | 19.6 |
| 10 years | 0.54 | | 309.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Windsor
CEO | Chief Executive Officer | 60 | 11/03/2024 |
| Director of Finance/CFO | 64 | 16/05/2024 | |
Cory Hogaboam
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Reinhard Ambros
BRD | Director/Board Member | 70 | 01/06/2013 |
| Chairman | 71 | 31/10/2023 | |
Brian Windsor
BRD | Director/Board Member | 60 | 11/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/27/26 A | Buy | Chairman | 4,500 | 0.0058% | ||
| 5/8/26 A | Free | Chief Executive Officer | -150,000 | 0.1922% | ||
| 11/14/25 A | Voss Capital LP
| Buy | Company | 104,183 | 0.4424% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.99% | +6.62% | -51.19% | -50.41% | 53.9M | |
| -0.21% | -4.43% | +44.40% | +74.13% | 66.22B | |
| +0.82% | +5.41% | +8.05% | +73.53% | 55.2B | |
| -0.22% | +6.53% | +11.68% | +87.32% | 52.79B | |
| +3.28% | +5.58% | +26.51% | +50.05% | 45.53B | |
| +0.51% | +9.95% | +22.40% | +133.92% | 43.94B | |
| -1.15% | +0.39% | +263.21% | +594.60% | 41.64B | |
| +0.10% | +9.90% | +16.11% | +59.33% | 34B | |
| -8.87% | -7.24% | +25.96% | -2.23% | 25.84B | |
| +0.69% | +5.60% | +36.60% | +26.94% | 23.51B | |
| Average | +0.01% | +4.33% | +40.37% | +104.72% | 38.87B | |
| Weighted average by Cap. | -0.15% | +3.73% | +49.47% | +126.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -29.15M -25.98M -24.05M -21.77M -41.01M -2.75B -41.49M -288M -113M -1.45B -109M -107M -4.61B | -37.01M -32.98M -30.54M -27.64M -52.07M -3.49B -52.68M -366M -144M -1.84B -139M -136M -5.85B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/10/26 | $0.6248 | +4.99% | 266,088 |
| 20/10/26 | $0.5951 | +7.81% | 296,443 |
| 19/10/26 | $0.5520 | -6.49% | 502,154 |
| 16/10/26 | $0.5903 | -6.00% | 372,098 |
| 15/10/26 | $0.6280 | +7.17% | 1,372,904 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RNTX Stock
Select your edition
All financial news and data tailored to specific country editions
